SBS-147 Safety Study
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is part of the HEAL Initiative supported by the NIH.
The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147.
Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results.
The study includes two parts:
Single-Dose Group, where Participants receive SBS-147 or placebo one time.
Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.
Who Is on the Research Team?
Jeff Reich, MD
Principal Investigator
Sparian Biosciences
Are You a Good Fit for This Trial?
Healthy adults aged 18-55, with a BMI of 18.0 to 32.0 kg/m2 and weighing at least 50 kg can join this trial. Participants must be willing to follow the study's procedures for its duration, non-smokers or have quit smoking for at least 90 days, and females must be able to bear children.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Single-Dose Group
Participants receive a single dose of SBS-147 or placebo and stay confined to the clinic for 5 days
Multiple-Dose Group
Participants receive SBS-147 or placebo once or twice daily for 7 days and stay confined to the clinic for 10 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- SBS-147
Trial Overview
The trial is testing SBS-147's safety and how it affects the body compared to a placebo (no medicine). It has two parts: one where participants take a single dose of SBS-147 or placebo, and another where they take it once or twice daily for seven days.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Single dose of SBS-147 or a placebo given during trial
SBS-147 or placebo given repeatedly over several days during the trial
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sparian Biosciences, Inc
Lead Sponsor
Altasciences Company Inc.
Industry Sponsor
National Institutes of Health (NIH)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.